Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jul 22, 2009

Polish University to Use Cellectricon’s Transfection System

  • The University of Lodz, Poland, will invest in Cellectricon’s Cellaxess®HT. The university plans to use the product for its research program focusing on cell biology and molecular genetics of clinically relevant genes related to cancer treatment.

    Cellaxess®HT is a fully automated workstation for high-throughput transfection. The system enables reagent-free delivery of siRNA and cDNA to a range of primary cells and cell lines.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »